Fundraising FoxGT Bio
1 known investors
Find your way into GT Bio
Sign up to see every warm intro you have to GT Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GT Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GT Bio develops an in vivo drug delivery atlas that combines drug delivery, targeted conjugates, spatial biology, and machine learning to enable cell type-specific delivery for precision medicine. The company generates in vivo delivery data intended to support the development of next-generation drug delivery systems for patients.
Founders & leadership
TS
Tay ShinFounderHe received the 2018 NSF Graduate Research Fellowship and a 2016 Ministerial Citation from the Korean Ministry of National Defence.
Investors · 1
Frequently asked questions
- What does GT Bio do?
- GT Bio develops an in vivo drug delivery atlas that combines drug delivery, targeted conjugates, spatial biology, and machine learning to enable cell type-specific delivery for precision medicine. The company generates in vivo delivery data intended to support the development of next-generation drug delivery systems for patients.
- Who founded GT Bio?
- GT Bio was founded by Tay Shin, Chi Zhang.
- Who are GT Bio's investors?
- GT Bio's investors include Fifty Years.